Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) hit a new 52-week high on Thursday . The company traded as high as $14.15 and last traded at $14.14, with a volume of 162324 shares. The stock had previously closed at $14.00.
Wall Street Analyst Weigh In
RBGLY has been the topic of a number of research analyst reports. Royal Bank of Canada restated an "outperform" rating on shares of Reckitt Benckiser Group in a research note on Friday, March 7th. Sanford C. Bernstein raised shares of Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a report on Thursday, June 5th. Two investment analysts have rated the stock with a hold rating, two have assigned a buy rating and four have issued a strong buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Buy".
View Our Latest Stock Analysis on RBGLY
Reckitt Benckiser Group Trading Down 1.8%
The company has a quick ratio of 0.47, a current ratio of 0.69 and a debt-to-equity ratio of 0.97. The business's fifty day moving average is $13.18 and its 200 day moving average is $12.93.
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Articles
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
